COMMUNIQUÉS West-GlobeNewswire

Immunicum AB (publ) Announces Positive Phase II MERECA Topline Results Including Complete Tumor Responses in Metastatic Renal Cell Carcinoma Patients
29/08/2019
Press Release 29 August 2019 Immunicum AB (publ) Announces Positive Phase II MERECA Topline Results Including Complete Tumor Responses in Metastatic Renal Cell Carcinoma Patients --Ilixadencel in combination with Sutent [...]
Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq
29/08/2019
This launch represents an important step in Roche’s personalised healthcare strategy to fit treatments to patients who can benefit most from a specific medicine Each year 300,000 patients around the world are diagnosed [...]
MDxHealth Reports Half Year 2019 Financial Results and Strategic Update
29/08/2019
Conference call with Q&A today at 11:00 CEST / 10:00 BST, details provided below IRVINE, CA, and HERSTAL, BELGIUM – August 29, 2019 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular [...]
MDxHealth dévoile ses résultats financiers pour le premier semestre de l’année 2019 et ses perspectives stratégiques
29/08/2019
Conférence téléphonique avec séance de questions-réponses aujourd’hui à 11 :00 CEST / 10:00 BST, voir détails ci-dessous IRVINE, CA, et HERSTAL, BELGIQUE – 29 août 2019 – MDxHealth SA (Euronext : MDXH.BR), une [...]
European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer
29/08/2019
The Tecentriq combination marks the first cancer immunotherapy regimen to be available in Europe for triple-negative breast cancer – an aggressive and difficult-to-treat disease Approval based on the Phase III [...]
Biocartis Group NV: BIOCARTIS ANNOUNCES 2019 HALF-YEAR RESULTS ON 5 SEPTEMBER 2019
29/08/2019
PRESS RELEASE: REGULATED INFORMATION Thursday 29 August 2019, 07:00 CEST BIOCARTIS ANNOUNCES 2019 HALF-YEAR RESULTS ON 5 SEPTEMBER 2019 Mechelen, Belgium , 29 August 20 19 – Biocartis Group NV (the ‘Company’ or ‘ [...]
Vistin Pharma ASA: Second quarter 2019 financial results
29/08/2019
Oslo, Norway, 29 August 2019 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter of 2019, with an increase in revenue of 11%. The revenues for the second quarter [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/08/2019
CRESTWOOD, Ky., and WALTHAM Mass, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
EDAP Reports 2019 Second Quarter Results
28/08/2019
Third consecutive profitable quarter Positive reimbursement decision by the American Medical Association announced in June Significant improvement in gross profit margin from 41.3% in Q2 2018 to 50.7% in Q2 2019 Q2 HIFU [...]
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
28/08/2019
U.S. District Court invalidates Amgen patent claims targeting PCSK9 Court rules in favor of Sanofi and Regeneron in ongoing Praluent ® (alirocumab) patent litigation PARIS and TARRYTOWN, NY – August 28, 2019 – Sanofi [...]
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
28/08/2019
Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9 Le tribunal statue en faveur de Sanofi et de Regeneron dans le cadre du litige en [...]
Osmotica Pharmaceuticals plc to Present at 2019 Wells Fargo Healthcare Conference
28/08/2019
BRIDGEWATER, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that Andrew Einhorn, Chief [...]
PLx Pharma Inc. to Present at Janney Healthcare Conference 2019 on September 10
28/08/2019
SPARTA, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]
Rockwell Medical, Inc. to Present at Upcoming September Conferences
28/08/2019
WIXOM, Mich., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to present at two [...]
Flexion Therapeutics to Present at the Wells Fargo Securities 2019 Healthcare Conference
28/08/2019
BURLINGTON, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led [...]
Atara Biotherapeutics to Participate in Citi 14th Annual Biotech Conference
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Related Matters Approved at Its AGM
28/08/2019
LAVAL, Quebec, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Corporation”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization [...]
Bellicum Pharmaceuticals to Participate in Three Healthcare Investor Conferences during September
28/08/2019
HOUSTON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
MyoKardia to Participate in September Investor Conferences
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced its participation in the following upcoming investor conferences: Citi 14 th Annual Biotech Conference in [...]

Pages